Insider · CIK 0001237401

HASTINGS DAVID C

Reports to the SEC for 7 companies · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001237401

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	SCYXSCYNEXIS INCA Award	Director	AAward	+2,875 sh	—	—	11,522
2026-06-26	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+2,875 sh	—	—	2,875
2026-01-08	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+375K sh	—	—	375,000
2025-06-26	SCYXSCYNEXIS INC · Stock OptionA Award	Director	AAward	+23K sh	—	—	23,000
2025-06-26	SCYXSCYNEXIS INCA Award	Director	AAward	+23K sh	—	—	69,183
2025-02-14	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+366K sh	—	—	365,800
2025-02-14	ABUSArbutus Biopharma CorpA Award	Chief Financial Officer	AAward	+90.1K sh	—	—	249,824
2025-02-04	ABUSArbutus Biopharma CorpS Sale	Chief Financial Officer	SSale	−22.2K sh	$3.28	−$72.8K	159,724
2024-06-20	SCYXSCYNEXIS INC · Stock OptionA Award	Director	AAward	+23K sh	—	—	23,000
2024-06-20	SCYXSCYNEXIS INCA Award	Director	AAward	+23K sh	—	—	46,183
2024-02-02	ABUSArbutus Biopharma CorpS Sale	Chief Financial Officer	SSale	−9,593 sh	$2.31	−$22.2K	181,907
2024-02-01	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+450K sh	—	—	450,000
2024-02-01	ABUSArbutus Biopharma CorpA Award	Chief Financial Officer	AAward	+113K sh	—	—	191,500
2023-06-15	SCYXSCYNEXIS INCA Award	Director	AAward	+10K sh	—	—	23,183
2023-06-15	SCYXSCYNEXIS INC · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2023-02-01	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+316K sh	—	—	316,000
2023-02-01	ABUSArbutus Biopharma CorpA Award	Chief Financial Officer	AAward	+79K sh	—	—	79,000
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director	JOther	−11K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director	JOther	−26.6K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−27.5K sh	$2.20	−$60.5K	0
2022-07-07	Entasis Therapeutics Holdings Inc.U Disposition from Tender	Director	UDisposition from Tender	−22K sh	$2.20	−$48.4K	0
2022-06-17	SCYXSCYNEXIS INCA Award	Director	AAward	+10K sh	—	—	13,183
2022-06-17	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-01-20	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+285K sh	$2.81	+$801K	285,000
2022-01-18	Entasis Therapeutics Holdings Inc.A Award	Director	AAward	+27.5K sh	—	—	49,500
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,276 sh	—	—	9,276
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,769 sh	—	—	5,769
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.5K sh	—	—	11,538
2021-07-16	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-06-16	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-04-01	Entasis Therapeutics Holdings Inc.A Award	Director	AAward	+22K sh	—	—	22,000
2021-02-13	ABUSArbutus Biopharma Corp · Stock OptionsA Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2020-07-06	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2020-07-06	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2020-06-10	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2020-02-17	ABUSArbutus Biopharma Corp · Stock OptionsA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2019-06-19	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2019-06-18	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2019-03-01	ABUSArbutus Biopharma Corp · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+138K sh	—	—	137,500
2019-01-18	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-01-02	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2018-06-19	ABUSArbutus Biopharma Corp · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2018-03-08	SCYXSCYNEXIS INC · Common Stock Warrant (right to buy)P Purchase	Director	PPurchase	+5,325 sh	—	—	5,325
2018-03-08	SCYXSCYNEXIS INCP Purchase	Director	PPurchase	+11.8K sh	$1.69	+$20K	31,834
2018-03-08	SCYXSCYNEXIS INC · Common Stock Warrant (right to buy)P Purchase	Director	PPurchase	+8,875 sh	—	—	8,875
2018-01-02	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	19,989
2017-06-21	SCYXSCYNEXIS INCP Purchase	Director	PPurchase	+20K sh	$1.75	+$35K	20,000
2017-01-26	Unilife CorpStock Option (Right to Buy)A Award	See Remarks	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jun 304
HASTINGS DAVID C0001237401-26-000002
SEC(opens sec.gov)
Jan 124
HASTINGS DAVID C0001193125-26-010361
SEC(opens sec.gov)
Jun 304
HASTINGS DAVID C0000950170-25-091589
SEC(opens sec.gov)
Feb 194
HASTINGS DAVID C0001447028-25-000050
SEC(opens sec.gov)
Feb 54
HASTINGS DAVID C0001447028-25-000040
SEC(opens sec.gov)
Jun 214
HASTINGS DAVID C0000950170-24-076239
SEC(opens sec.gov)
Feb 54
HASTINGS DAVID C0001447028-24-000027
SEC(opens sec.gov)
Jun 234
HASTINGS DAVID C0000950170-23-029609
SEC(opens sec.gov)
Jun 204
HASTINGS DAVID C0000950170-23-029046
SEC(opens sec.gov)
Feb 34
HASTINGS DAVID C0001447028-23-000009
SEC(opens sec.gov)
Jul 114
HASTINGS DAVID C0001104659-22-078789
SEC(opens sec.gov)

Companies

Address

1 EVERTRUST PLAZA 13TH FLOOR

JERSEY CITY, NJ, 07302-6548